Barr Pharmaceutical's Seasonale patent re-issued

Barr Pharmaceuticals, Inc. has announced that the U.S. Patent and Trademark Office (PTO) has reissued the Company's patent, U.S. Patent No. 5,898,032, for Seasonale extended-cycle oral contraceptive.

The reissued patent has a new number, RE39861, and the same expiration date of June 23, 2017.

"We are pleased that the PTO has reissued our patent protecting SEASONALE(R) extended-cycle oral contraceptive.

The reissued patent confirms our position that we have the exclusive right to market SEASONALE(R)," said Bruce L. Downey, Barr's Chairman and CEO.